p16INK4a Is a Useful Marker for the Diagnosis of Adenocarcinoma of the Cervix Uteri and Its Precursors: An Immunohistochemical Study With Immunocytochemical Correlations

p16INK4a is a tumor suppressor gene that plays a central role in the regulation of the cell cycle. In squamous cervical cancers, overexpression of p16INK4a is induced by HPV and associated with the carcinogenesis of cervical epithelia. The aim of this study was to determine whether immunostaining of p16INK4a is useful in detecting adenocarcinomas of the cervix uteri in histologic and cytologic routine specimens. A total of 45 surgical specimens, including 18 cases of invasive carcinoma, 8 cases of adenocarcinoma in situ, 4 cases of endocervical glandular atypia (cervical glandular intraepithelial neoplasia), and 15 reactive lesions of the endocervical glands were immunostained using a specific anti-human p16INK4a monoclonal antibody (clone E6H4, mtm laboratories AG, Heidelberg, Germany). Furthermore, immunocytochemical analysis was performed on 10 preoperative ThinPrep cytologic samples with abnormal glandular cells and compared with the human papillomavirus status as assessed with the Hybrid Capture II test. p16INK4a was detected immunohistochemically in all 26 cases of adenocarcinoma of the cervix uteri, including 18 invasive and 8 in situ carcinomas. Only a focal expression was evidenced in the four specimens with endocervical glandular atypia, and no reaction was found in reactive lesions. Also, the immunocytochemical analysis on the 10 ThinPrep specimens evidenced a strong expression of p16INK4a in neoplastic endocervical cells. In all cases this was associated with a high-risk HPV-positive typing. p16INK4a is a useful marker for the detection of the adenocarcinoma of the cervix uteri and its precursors. The immunocytochemical detection on ThinPrep specimens may contribute to an early detection of endocervical lesions.

[1]  M. Bibbo,et al.  Procedure for Immunocytochemical Detection of P16INK4A Antigen in Thin-Layer, Liquid-Based Specimens , 2002, Acta Cytologica.

[2]  M. von Knebel Doeberitz,et al.  Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri , 2001, International journal of cancer.

[3]  S. Riethdorf,et al.  Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas , 2001, Virchows Archiv.

[4]  S. Granter,et al.  Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix , 2001, Cancer.

[5]  I. Ron,et al.  Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral. , 2000, Gynecologic oncology.

[6]  M. Quinn,et al.  Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. , 2000, Gynecologic oncology.

[7]  R. Zaino Glandular Lesions of the Uterine Cervix , 2000, Modern Pathology.

[8]  S. Saltzstein,et al.  Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening. , 1999, Gynecologic oncology.

[9]  C. Clavel,et al.  Hybrid Capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: a preliminary study on 1518 women , 1999, British Journal of Cancer.

[10]  C. Sung,et al.  ThinPrep® pap test promotes detection of glandular lesions of the endocervix , 1999, Diagnostic cytopathology.

[11]  T. Nakajima,et al.  Immunohistochemical overexpression of p16 protein associated with intact retinoblastoma protein expression in cervical cancer and cervical intraepithelial neoplasia , 1998, Pathology international.

[12]  V. Moreno,et al.  International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas , 1998, International journal of cancer.

[13]  T. Denehy,et al.  Endocervical Curettage, Cone Margins, and Residual Adenocarcinoma In Situ of the Cervix , 1997, Obstetrics and gynecology.

[14]  A. Sabichi,et al.  Molecular characterization of adenocarcinoma of the cervix. , 1997, Gynecologic oncology.

[15]  R. Zappatore,et al.  Human papillomavirus types 16 and 18 infection in infiltrating adenocarcinoma of the cervix: PCR analysis of 138 cases and correlation with histologic type and grade. , 1996, American journal of clinical pathology.

[16]  G. Kristensen,et al.  Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer. , 1991, Acta cytologica.

[17]  E. Wilander,et al.  The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. , 2001, European journal of cancer.